Review





Similar Products

bt 474  (ATCC)
99
ATCC bt 474
Bt 474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt+474/BT-474/pm42994959-43-7-16
Average 99 stars, based on 1 article reviews
bt 474 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC bt 474 cells
(A, C, E) Representative phase-contrast images of SK-BR-3 (A) , MDA-MB-231 (C) , and <t>BT-474</t> (E) cells maintained in 100% DM on uncoated plates or plates coated with vitronectin (VN; 0.5 µg/cm²), fibronectin (FN; 1.0 µg/cm²), combined FN/VN (0.5 µg/cm² each), or FBS-derived coating, as indicated. (B, D, F) Cumulative population doublings of SK-BR-3 (B) , MDA-MB-231 (D) , and BT-474 (F) cells cultured in 100% DM on the coating conditions shown above. The coating conditions selected for subsequent maintenance of SK-BR-3 and MDA-MB-231 cells are shown in and , respectively. FN-coated plates were used to evaluate BT-474 cells following transfer to 100% DM, although no coating condition supported sustained proliferation. Scale bars, 150 µm.
Bt 474 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt+474/BT-474/bio_rxiv__64898__2026__11__02__762606-187-3-8
Average 99 stars, based on 1 article reviews
bt 474 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

bt474  (ATCC)
99
ATCC bt474
(A, C, E) Representative phase-contrast images of SK-BR-3 (A) , MDA-MB-231 (C) , and <t>BT-474</t> (E) cells maintained in 100% DM on uncoated plates or plates coated with vitronectin (VN; 0.5 µg/cm²), fibronectin (FN; 1.0 µg/cm²), combined FN/VN (0.5 µg/cm² each), or FBS-derived coating, as indicated. (B, D, F) Cumulative population doublings of SK-BR-3 (B) , MDA-MB-231 (D) , and BT-474 (F) cells cultured in 100% DM on the coating conditions shown above. The coating conditions selected for subsequent maintenance of SK-BR-3 and MDA-MB-231 cells are shown in and , respectively. FN-coated plates were used to evaluate BT-474 cells following transfer to 100% DM, although no coating condition supported sustained proliferation. Scale bars, 150 µm.
Bt474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt+474/BT-474/10__1016_slash_s1875___5364_ascii40_26_ascii41_61227___7-39-10-14
Average 99 stars, based on 1 article reviews
bt474 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human her2 positive breast cancer cell line bt 474
(A) . Schematic representation of the experimental workflow. NK cells were isolated from PBMCs of healthy donors by magnetic separation and subsequently sorted into aNK and cNK subsets based on NKG2C expression by fluorescence-activated cell sorting (FACS). Purified NK-cell subsets were then co-cultured with immature monocyte-derived DCs in the presence or absence of BT474 cells, either untreated or opsonized with trastuzumab (TRZ). (B) Expression of DCs maturation markers, CD83 (left), CD80 (middle) and CD86 (right), after co-culture with <t>BT-474</t> cells plus TRZ, modulated by aNK or cNK cells (n=5) Wald-test. Created with BioRender.com .
Human Her2 Positive Breast Cancer Cell Line Bt 474, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt+474/BT-474/pmc13748290-59-1-8
Average 99 stars, based on 1 article reviews
human her2 positive breast cancer cell line bt 474 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC bt 47431
(A) . Schematic representation of the experimental workflow. NK cells were isolated from PBMCs of healthy donors by magnetic separation and subsequently sorted into aNK and cNK subsets based on NKG2C expression by fluorescence-activated cell sorting (FACS). Purified NK-cell subsets were then co-cultured with immature monocyte-derived DCs in the presence or absence of BT474 cells, either untreated or opsonized with trastuzumab (TRZ). (B) Expression of DCs maturation markers, CD83 (left), CD80 (middle) and CD86 (right), after co-culture with <t>BT-474</t> cells plus TRZ, modulated by aNK or cNK cells (n=5) Wald-test. Created with BioRender.com .
Bt 47431, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bt+474/BT-474/10__1093_slash_asjof_slash_ojag215-51-3-4
Average 99 stars, based on 1 article reviews
bt 47431 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


(A, C, E) Representative phase-contrast images of SK-BR-3 (A) , MDA-MB-231 (C) , and BT-474 (E) cells maintained in 100% DM on uncoated plates or plates coated with vitronectin (VN; 0.5 µg/cm²), fibronectin (FN; 1.0 µg/cm²), combined FN/VN (0.5 µg/cm² each), or FBS-derived coating, as indicated. (B, D, F) Cumulative population doublings of SK-BR-3 (B) , MDA-MB-231 (D) , and BT-474 (F) cells cultured in 100% DM on the coating conditions shown above. The coating conditions selected for subsequent maintenance of SK-BR-3 and MDA-MB-231 cells are shown in and , respectively. FN-coated plates were used to evaluate BT-474 cells following transfer to 100% DM, although no coating condition supported sustained proliferation. Scale bars, 150 µm.

Journal: bioRxiv

Article Title: Adaptation of breast cancer cells to serum-free defined medium reveals changes in proliferation, adhesion, and lipid metabolism

doi: 10.64898/2026.11.02.762606

Figure Lengend Snippet: (A, C, E) Representative phase-contrast images of SK-BR-3 (A) , MDA-MB-231 (C) , and BT-474 (E) cells maintained in 100% DM on uncoated plates or plates coated with vitronectin (VN; 0.5 µg/cm²), fibronectin (FN; 1.0 µg/cm²), combined FN/VN (0.5 µg/cm² each), or FBS-derived coating, as indicated. (B, D, F) Cumulative population doublings of SK-BR-3 (B) , MDA-MB-231 (D) , and BT-474 (F) cells cultured in 100% DM on the coating conditions shown above. The coating conditions selected for subsequent maintenance of SK-BR-3 and MDA-MB-231 cells are shown in and , respectively. FN-coated plates were used to evaluate BT-474 cells following transfer to 100% DM, although no coating condition supported sustained proliferation. Scale bars, 150 µm.

Article Snippet: MDA-MB-231, SK-BR-3, and BT-474 cells were obtained from ATCC and maintained in CM prior to adaptation.

Techniques: Phase Contrast, Derivative Assay, Cell Culture

(A) Cumulative population doublings of MDA-MB-231 cells during stepwise adaptation to DM. (B) Representative phase-contrast images of parental MDA-MB-231 cells maintained in CM, cells at the 10:90 CM:DM adaptation stage, and cells maintained in 100% DM on VN-coated plates. (C) Cumulative population doublings of parental, 10:90, and adapted 100% DM MDA-MB-231 cultures. (D) Cumulative population doublings of BT-474 cells during stepwise adaptation. (E) Representative phase-contrast images of parental BT-474 cells maintained in CM, cells at the 10:90 CM:DM adaptation stage, and cells transferred to 100% DM on FN-coated plates. (F) Cumulative population doublings of parental, 10:90, and 100% DM BT-474 cultures. Scale bars, 150 µm.

Journal: bioRxiv

Article Title: Adaptation of breast cancer cells to serum-free defined medium reveals changes in proliferation, adhesion, and lipid metabolism

doi: 10.64898/2026.11.02.762606

Figure Lengend Snippet: (A) Cumulative population doublings of MDA-MB-231 cells during stepwise adaptation to DM. (B) Representative phase-contrast images of parental MDA-MB-231 cells maintained in CM, cells at the 10:90 CM:DM adaptation stage, and cells maintained in 100% DM on VN-coated plates. (C) Cumulative population doublings of parental, 10:90, and adapted 100% DM MDA-MB-231 cultures. (D) Cumulative population doublings of BT-474 cells during stepwise adaptation. (E) Representative phase-contrast images of parental BT-474 cells maintained in CM, cells at the 10:90 CM:DM adaptation stage, and cells transferred to 100% DM on FN-coated plates. (F) Cumulative population doublings of parental, 10:90, and 100% DM BT-474 cultures. Scale bars, 150 µm.

Article Snippet: MDA-MB-231, SK-BR-3, and BT-474 cells were obtained from ATCC and maintained in CM prior to adaptation.

Techniques: Phase Contrast

(A) Representative immunofluorescence images of HER2 and Ki-67 in parental SK-BR-3 cells and adapted cells maintained in 100% DM on serum-coated plates. (B) Quantification of HER2 mean fluorescence intensity. (C) Percentage of Ki-67-positive cells. (D–F) Representative immunofluorescence images of vimentin and Ki-67 (D) , quantification of vimentin mean fluorescence intensity (E) , and percentage of Ki-67-positive cells (F) in parental and adapted MDA-MB-231 cells maintained in 100% DM. (G–I) Representative immunofluorescence images of HER2 and Ki-67 (G) , quantification of HER2 mean fluorescence intensity (H) , and percentage of Ki-67-positive cells (I) in parental BT-474 cells and cells maintained at the 10:90 CM:DM adaptation stage. Phalloidin and DAPI label F-actin and nuclei, respectively. Representative images were acquired using a 63× objective; quantitative measurements were obtained from 20× montage images. Cell numbers quantified for SK-BR-3: n = 1,394 for parental and n = 333 for adapted; for MDA-MB-231: n = 1,786 for parental and n = 1,054 for adapted; and for BT-474: n = 2,729 and n = 1,193. Box plots show the median and interquartile range, with whiskers extending to 1.5× the interquartile range. Bar graphs show the mean ± SEM. ****P < 0.0001, two-sided Wilcoxon rank-sum test with Benjamini-Hochberg correction. Antibody and reagent information is provided in Table S2.

Journal: bioRxiv

Article Title: Adaptation of breast cancer cells to serum-free defined medium reveals changes in proliferation, adhesion, and lipid metabolism

doi: 10.64898/2026.11.02.762606

Figure Lengend Snippet: (A) Representative immunofluorescence images of HER2 and Ki-67 in parental SK-BR-3 cells and adapted cells maintained in 100% DM on serum-coated plates. (B) Quantification of HER2 mean fluorescence intensity. (C) Percentage of Ki-67-positive cells. (D–F) Representative immunofluorescence images of vimentin and Ki-67 (D) , quantification of vimentin mean fluorescence intensity (E) , and percentage of Ki-67-positive cells (F) in parental and adapted MDA-MB-231 cells maintained in 100% DM. (G–I) Representative immunofluorescence images of HER2 and Ki-67 (G) , quantification of HER2 mean fluorescence intensity (H) , and percentage of Ki-67-positive cells (I) in parental BT-474 cells and cells maintained at the 10:90 CM:DM adaptation stage. Phalloidin and DAPI label F-actin and nuclei, respectively. Representative images were acquired using a 63× objective; quantitative measurements were obtained from 20× montage images. Cell numbers quantified for SK-BR-3: n = 1,394 for parental and n = 333 for adapted; for MDA-MB-231: n = 1,786 for parental and n = 1,054 for adapted; and for BT-474: n = 2,729 and n = 1,193. Box plots show the median and interquartile range, with whiskers extending to 1.5× the interquartile range. Bar graphs show the mean ± SEM. ****P < 0.0001, two-sided Wilcoxon rank-sum test with Benjamini-Hochberg correction. Antibody and reagent information is provided in Table S2.

Article Snippet: MDA-MB-231, SK-BR-3, and BT-474 cells were obtained from ATCC and maintained in CM prior to adaptation.

Techniques: Immunofluorescence, Fluorescence

(A, D, G) Principal component analysis of parental and adapted SK-BR-3, MDA-MB-231, and BT-474 cells, respectively. (B, E, H) Volcano plots showing differential gene expression in adapted relative to parental cells. Differentially expressed genes were defined by an adjusted P value < 0.05 and an absolute log, fold change > 1; genes meeting these criteria are colored according to the direction of change. (C, F, I) Gene set enrichment analysis using Hallmark gene sets in SK-BR-3, MDA-MB-231, and BT-474 cells, respectively. Positive normalized enrichment scores (NES) indicate enrichment in adapted cells, whereas negative NES indicate enrichment in parental cells; dot size represents the number of genes contributing to each gene set. SK-BR-3 and MDA-MB-231 cells were analyzed following adaptation to 100% DM, whereas BT-474 cells were analyzed at the 10:90 CM:DM adaptation stage (1% FBS).

Journal: bioRxiv

Article Title: Adaptation of breast cancer cells to serum-free defined medium reveals changes in proliferation, adhesion, and lipid metabolism

doi: 10.64898/2026.11.02.762606

Figure Lengend Snippet: (A, D, G) Principal component analysis of parental and adapted SK-BR-3, MDA-MB-231, and BT-474 cells, respectively. (B, E, H) Volcano plots showing differential gene expression in adapted relative to parental cells. Differentially expressed genes were defined by an adjusted P value < 0.05 and an absolute log, fold change > 1; genes meeting these criteria are colored according to the direction of change. (C, F, I) Gene set enrichment analysis using Hallmark gene sets in SK-BR-3, MDA-MB-231, and BT-474 cells, respectively. Positive normalized enrichment scores (NES) indicate enrichment in adapted cells, whereas negative NES indicate enrichment in parental cells; dot size represents the number of genes contributing to each gene set. SK-BR-3 and MDA-MB-231 cells were analyzed following adaptation to 100% DM, whereas BT-474 cells were analyzed at the 10:90 CM:DM adaptation stage (1% FBS).

Article Snippet: MDA-MB-231, SK-BR-3, and BT-474 cells were obtained from ATCC and maintained in CM prior to adaptation.

Techniques: Analysis, Gene Expression, Gene Set Enrichment Analysis

(A) . Schematic representation of the experimental workflow. NK cells were isolated from PBMCs of healthy donors by magnetic separation and subsequently sorted into aNK and cNK subsets based on NKG2C expression by fluorescence-activated cell sorting (FACS). Purified NK-cell subsets were then co-cultured with immature monocyte-derived DCs in the presence or absence of BT474 cells, either untreated or opsonized with trastuzumab (TRZ). (B) Expression of DCs maturation markers, CD83 (left), CD80 (middle) and CD86 (right), after co-culture with BT-474 cells plus TRZ, modulated by aNK or cNK cells (n=5) Wald-test. Created with BioRender.com .

Journal: Frontiers in Immunology

Article Title: Characterization and ex vivo functional properties of NKG2C + NK cells with adaptive features in breast tumors

doi: 10.3389/fimmu.2026.1995578

Figure Lengend Snippet: (A) . Schematic representation of the experimental workflow. NK cells were isolated from PBMCs of healthy donors by magnetic separation and subsequently sorted into aNK and cNK subsets based on NKG2C expression by fluorescence-activated cell sorting (FACS). Purified NK-cell subsets were then co-cultured with immature monocyte-derived DCs in the presence or absence of BT474 cells, either untreated or opsonized with trastuzumab (TRZ). (B) Expression of DCs maturation markers, CD83 (left), CD80 (middle) and CD86 (right), after co-culture with BT-474 cells plus TRZ, modulated by aNK or cNK cells (n=5) Wald-test. Created with BioRender.com .

Article Snippet: The human HER2-positive breast cancer cell line BT-474 (ATCC HTB-20) was maintained in DMEM/F12 medium supplemented with 10% fetal bovine serum (FBS; Natocor), 3.5 ng/mL sodium selenite, 0.1 mM ascorbic acid, 300 μg/mL galactose, 13.6 mM sodium pyruvate, 5 μg/mL recombinant human insulin, 0.29 mg/mL L-glutamine, 100 U/mL penicillin, and 10 μg/mL streptomycin at 37 °C in a humidified incubator containing 5% CO 2 .

Techniques: Isolation, Expressing, Fluorescence, FACS, Purification, Cell Culture, Derivative Assay, Co-culture Assay, Co-Culture, Flow Cytometry